MeiraGTx Holdings (MGTX) Exchange Rate Effect (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Exchange Rate Effect came in at $217000.0 in Q4 2025, down 75.59% YoY from $889000.0 in Q4 2024, and up 105.0% on a QoQ basis from -$4.3 million in Q3 2025.
MeiraGTx Holdings (MGTX) Exchange Rate Effect (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Exchange Rate Effect data on file, last reported at $217000.0 in Q4 2025.
- Quarterly Exchange Rate Effect fell 75.59% year-over-year to $217000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $719000.0 (down 52.1% YoY) and the FY2025 annual result came in at $719000.0, down 52.1% from the prior year.
- Exchange Rate Effect climbed to $217000.0 in Q4 2025, from -$4.3 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $5.1 million in Q2 2025 to a low of -$4.3 million in Q3 2025.
- A 5-year average of $202850.0 and a median of $123500.0 in 2021 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 8844.83% in 2025, down 1232.38% in 2025.
- Tracing MGTX's Exchange Rate Effect over 5 years: stood at -$685000.0 in 2021, then jumped by 207.45% to $736000.0 in 2022, then surged by 158.7% to $1.9 million in 2023, then slumped by 53.31% to $889000.0 in 2024, then plunged by 75.59% to $217000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $217000.0 (Q4 2025), -$4.3 million (Q3 2025), and $5.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 217,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 217,000.00 |
| Dec 31, 2025 | 217,000.00 |
| Sep 30, 2025 | -4.34 Mn |
| Sep 30, 2025 | -4.34 Mn |
| Jun 30, 2025 | 5.07 Mn |
| Jun 30, 2025 | 5.07 Mn |
| Mar 31, 2025 | -233,000.00 |
| Mar 31, 2025 | -233,000.00 |
| Dec 31, 2024 | 889,000.00 |
| Dec 31, 2024 | 889,000.00 |
| Sep 30, 2024 | 383,000.00 |
| Sep 30, 2024 | 383,000.00 |
| Jun 30, 2024 | -58,000.00 |
| Jun 30, 2024 | -58,000.00 |
| Mar 31, 2024 | 287,000.00 |
| Mar 31, 2024 | 287,000.00 |
| Dec 31, 2023 | 1.90 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 12,000.00 |
| Sep 30, 2023 | 12,000.00 |